P1073

Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children < 72 months of Age

Sponsors: US National Institute of Allergy and Infectious Diseases (NIAID)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Protocol Summary: P1073 is a two-step, prospective observational study examining tuberculosis (TB) or Bacille Calmette Guerin (BCG) vaccine related to IRIS after initiating HAART. The study aims to describe the incidence, severity, clinical features of IRIS events related to BCG (BCG-IRIS) and TB infection (TB-IRIS) or OTHER-IRIS in ARV treatment naïve HIV-infected pediatric patients starting HAART for the first time.

Years: 2011 – 2014

Investigator: Hilda Mujuru, MBChB, MMED, MSc Cli.Epi

Location: Parirenyatwa CRS

IMPAACT

Completed Study

Publication:

Comments are closed.

Website by Canton Becker